Details of the Drug Reposition

General Information of This Drug (ID: DMDM2DF)

Drug Name
CLR-131   DMDM2DF

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Multiple myeloma DISEWP9B 2A83 Phase 2 [1]
Haematological malignancy DISCDP7W 2B33.Y Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pediatric cancer DISWYLB3 2A00-2F9Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)